"Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants," said Dr. Peter Marks, Director of the FDA's Center for Biologics Evaluation and Research.
"Then the administration should continue through September, October, November, those are the months you really want to be paying attention to," she said.
"FDA has committed to moving swiftly on regulatory authorization. We expect to have authorization in time for peak vaccination season," Novavax said in a statement.
The decision clears the way for distribution to begin for the latest version of the shots earlier this year than last year.
Collection
[
|
...
]